Agilent Says Rival's DNA Patent Based On Law Of Nature

Law360, San Francisco (March 6, 2014, 7:55 PM EST) -- Agilent Technologies Inc. urged a California federal judge on Thursday to toss Genetic Technologies Ltd.'s lawsuit accusing Agilent of selling a DNA-testing device that infringes GT's patent on genetic analysis technology, arguing that GT's patent is invalid because it's based on an unpatentable natural phenomenon.

Agilent told U.S. District Court Judge Richard Seeborg that its 2100 Bioanalyzer product couldn't infringe GT's U.S. Patent Number 5,612,179 because the patent wasn't valid, particularly given recent U.S. Supreme Court rulings barring “laws of nature” from being patentable.

“There's nothing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.